PROBIOTICS AS ADDITIONAL TREATMENT OF RHEUMATOID ARTHRITIS. A REVIEW.
Relevance. Rheumatoid arthritis (RA) is a condition with an unclear cause, marked by inflammation affecting the synovial tissue of joints, cartilage, and bone. RA can extend to areas outside the joints, autoantibodies production and progressive disability. Rheumatoid arthritis affects approximately 0.24% to 1% of adults globally, with women being affected 2 to 3 times more frequently than men. In recent years numerouse studies showed the significant role of micribiome in RA developement. Regardless of using disease-modifying anti-rheumatic drugs (DMARDs) and biologic therapies, a significant number of patients with RA fail to achieve remission. These two facts have prompted interest in targeting the microbiome as a therapeutic strategy for RA.
Aim: To analyze the effectiveness of probiotics in the treatment of RA according to contemporary literature.
Search strategy: A search for scientific publications was carried out in the following databases of scientific publications and specialized search engines: PubMed, Google Scholar, Web of Science Core Collection, Cochrane Library. A number of original publicly available publications on the research topic were analyzed. The search depth was 10 years. As a result of the search, we studied 579 foreign publications, of which 84 publications were included in this review. Inclusion criteria: meta-analyses, systematic reviews, cohort and cross-sectional studies. Exclusion criteria: short reports, newspaper articles and expert opinion in the form of short reports.
Results and conclusions: The review revealed that probiotics can influence the microbiome and immune system of RA patients through various mechanisms of action. In addition, it has been found that the use of L. Casei alone and in combination with L. acidophilus, L. Lactis, B. Lactis and B. bifidum, as well as Bacillus coagulans can improve the course of RA, reduce the level of inflammatory markers and pro-inflammatory cytokines. Given the conflicting evidence regarding the effectiveness of probiotics in the treatment of RA, further research is needed.
Aigerim K. Ibraeva1, https://orcid.org/0000-0003-0628-9370
Natalya A. Latypova1, https://orcid.org/0000-0003-4283-4911
Almagul R. Kushugulova2, https://orcid.org/0000-0001-9479-0899
Assel M. Meiramova1, https://orcid.org/0000-0002-4030-0783
Bibigul B. Adilbekova1,
Argul A. Isilbaeva2, https://orcid.org/0000-0002-7350-6083
Samat S. Kozhakhmetov2, https://orcid.org/0000-0001-9668-0327
1. Abid R., Waseem H., Ali J. et al. Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. JoF, 2022. 8(5). P. 444.
2. Ajeganova S., Huizinga T. Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations. Therapeutic Advances in Musculoskeletal, 2017. 9(10). P. 249-262.
3. Albenberg L.G., Wu G.D. Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease. Gastroenterology, 2014. 146(6). P. 1564-1572.
4. Aleman R.S., Yadav A. Systematic Review of Probiotics and Their Potential for Developing Functional Nondairy Foods. Applied Microbiology, 2023. 4(1). P. 47-69.
5. Alipour B., Homayouni‐Rad A., Vaghef‐Mehrabany E., et al. Effects of L actobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trial. Int J of Rheum Dis., 2014. 17(5). P. 519-527.
6. Alpizar-Rodriguez D., Lesker T.R., Gronow A. et al. Prevotella copri in individuals at risk for rheumatoid arthritis. Ann Rheum Dis, 2019. 78(5). P. 590-593.
7. Amdekar S., Singh V., Kumar A., Sharma P., Singh R. Lactobacillus casei and Lactobacillus acidophilus Regulate Inflammatory Pathway and Improve Antioxidant Status in Collagen-Induced Arthritic Rats. Journal of Interferon & Cytokine Research, 2013. 33(1). P. 1-8.
8. Argyri A.A., Zoumpopoulou G., Karatzas K.A.G. et al. Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests. Food Microbiology, 2013. 33(2). P. 282-291.
9. Baccouri O., Boukerb A.M., Farhat L.B. et al. Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis. Front Microbiol, 2019. 10. P. 881.
10. Bagci U., Ozmen Togay S., Temiz A., Ay M. Probiotic characteristics of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum. Folia Microbiol, 2019. 64(6). P. 735-750.
11. Bauer M.A., Kainz K., Carmona-Gutierrez D., Madeo F. Microbial wars: competition in ecological niches and within the microbiome. Microb Cell, 2018. 5(5). P. 215-219.
12. Bidossi A., De Grandi R., Toscano M. et al. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract. BMC Infect Dis, 2018. 8(1). P. 653.
13. Bindels L.B., Delzenne N.M., Cani P.D., and Walter J. Advances in Probiotics for Sustainable Food and Medicine, 2021. Vol 21.
14. Bodkhe R., Balakrishnan B., Taneja V. The role of microbiome in rheumatoid arthritis treatment. Therapeutic Advances in Musculoskeletal, 2019. 11.
15. Bradley C.P., Teng F., Felix K.M. et al. Segmented Filamentous Bacteria Provoke Lung Autoimmunity by Inducing Gut-Lung Axis Th17 Cells Expressing Dual TCRs. Cell Host & Microbe, 2017. 22(5). P. 697-704.
16. Bubnov R.V., Babenko L.P., Lazarenko L.M., Mokrozub V.V., Spivak M.Ya. Specific properties of probiotic strains: relevance and benefits for the host. EPMA Journal, 2018. 9(2). P. 205-223.
17. Cai Y., Zhang J., Liang J. et al. The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis. JCM, 2023. 12(4). P. 1291.
18. Cani P.D. Human gut microbiome: hopes, threats and promises. Gut, 2018. 67(9). P. 1716-1725.
19. Cannarella L.A.T., Mari N.L., Alcântara C.C. et al. Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis. Nutrition, 2021. 89. P. 111282.
20. Chandrasekaran P., Weiskirchen S., Weiskirchen R. Effects of Probiotics on Gut Microbiota: An Overview. IJMS, 2024. 25(11). P. 6022.
21. Chen J., Wright K., Davis J.M. et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med, 2016. 8(1). P. 43.
22. Cheng Z., Meade J., Mankia K., Emery P., Devine D.A. Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 2017. 31(1). P. 19-30.
23. Cristofori F., Dargenio V.N., Dargenio C., Miniello V.L., Barone M., Francavilla R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol, 2021. 12.
24. Damián M.R., Cortes-Perez N.G., Quintana E.T., et al. Functional Foods, Nutraceuticals and Probiotics: A Focus on Human Health. Microorganisms, 2022. 10(5). P. 1065.
25. Davison E., Johnston W., Piela K. et al. The Subgingival Plaque Microbiome, Systemic Antibodies against Bacteria and Citrullinated Proteins following Periodontal Therapy. Pathogens, 2021. 10(2). P. 193.
26. Diamanti A.P., Manuela Rosado M., Laganà B., D’Amelio R. Microbiota and chronic inflammatory arthritis: an interwoven link. J Transl Med, 2016. 14(1). P. 233.
27. Du Teil Espina M. Tricking the Gatekeepers: Subversion of Host Immune Responses by Porphyromonas Gingivalis: University of Groningen, 2022.
28. Esvaran M., Conway P.L. Lactobacillus fermentum PC1 has the Capacity to Attenuate Joint Inflammation in Collagen-Induced Arthritis in DBA/1 Mice. Nutrients, 2019. 11(4). P. 785.
29. Ghelardi E., Abreu Y., Abreu A.T., Marzet C.B., Álvarez Calatayud G., Perez M., Moschione Castro A.P. Current Progress and Future Perspectives on the Use of Bacillus clausii. Microorganisms, 2022. 10(6). P. 1246.
30. Gou H.Z., Zhang Y.L., Ren L.F., Li Z.J., Zhang L. How do intestinal probiotics restore the intestinal barrier? Front Microbiol, 2022. 13.
31. Gul H.L., Eugenio G., Rabin T. et al. Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes. Rheumatology, 2020. 59(3). 613-621.
32. Haber A.L., Biton M., Rogel N. et al. A single-cell survey of the small intestinal epithelium. Nature, 2017. 551(7680). P. 333-339.
33. Hajishengallis G., Diaz P.I. Porphyromonas gingivalis: Immune Subversion Activities and Role in Periodontal Dysbiosis. Curr Oral Health Rep, 2020. 7(1). P. 12-21.
34. Hanchi H., Mottawea W., Sebei K., Hammami R. The Genus Enterococcus: Between Probiotic Potential and Safety Concerns - An Update. Front Microbiol, 2018. 9. P. 1791.
35. Hatakka K., Martio J., Korpela M. et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot study. Scandinavian Journal of Rheumatology, 2003. 32(4). P. 211-215.
36. Hetz C., Zhang K., Kaufman R.J. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol, 2020. 21(8). P. 421-438.
37. Hills R., Pontefract B., Mishcon H., Black C., Sutton S., Theberge C. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients, 2019. 11(7). P. 1613.
38. Homayouni Rad A., Torab R., Ghalibaf M., Norouzi S., Mehrabany E.V. Might patients with immune-related diseases benefit from probiotics? Nutrition, 2013. 29(3). P. 583-586.
39. Kang Y., Cai Y., Zhang X., Kong X., Su J. Altered gut microbiota in RA: implications for treatment. Z Rheumatol, 2017. 76(5). P. 451-457.
40. Khan R., Petersen F.C., Shekhar S. Commensal Bacteria: An Emerging Player in Defense Against Respiratory Pathogens. Front Immunol, 2019. 10. P. 1203.
41. Kim J.E., Chae C.S., Kim G.C. et al. Lactobacillus helveticus suppresses experimental rheumatoid arthritis by reducing inflammatory T cell responses. Journal of Functional Foods, 2015. 13. P. 350-362.
42. Konig M.F., Abusleme L., Reinholdt J. et al. Aggregatibacter actinomycetemcomitans – induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med, 2016. 8. P. 369.
43. Lee G.R. The Balance of Th17 versus Treg Cells in Autoimmunity. IJMS, 2018. 19(3). P. 730.
44. Li J., Sung C.Y.J., Lee N. et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci USA, 2016. 113(9).
45. Liu X., Tian K., Ma X., Wang S., Luo C., Du Q. Analysis of subgingival microbiome of periodontal disease and rheumatoid arthritis in Chinese: A case-control study. Saudi Journal of Biological Sciences, 2020. 27(7). P. 1835-1842.
46. Liu X., Zhang J., Zou Q. et al. Lactobacillus salivarius Isolated from Patients with Rheumatoid Arthritis Suppresses Collagen-Induced Arthritis and Increases Treg Frequency in Mice. Journal of Interferon & Cytokine Research, 2016. 36(12). P. 706-712.
47. Maeda Y., Kurakawa T., Umemoto E. et al. Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Arthritis & Rheumatology, 2016. 68(11). P. 2646-2661.
48. Maldonado Galdeano C., Cazorla S.I., Lemme Dumit J.M., Vélez E., Perdigón G. Beneficial Effects of Probiotic Consumption on the Immune System. Ann Nutr Metab, 2019. 74(2). P. 115-124.
49. Mandel D.R., Eichas K., Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med., 2010. 10(1).
50. Maria de los Angeles Pineda, Sarah Frances Thompson, Kelly Summers, Faye de Leon, Janet Pope, Gregor Reid. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit. 2011. 17(6). P. 347-354.
51. Marietta E.V., Murray J.A., Luckey D.H. et al. Suppression of Inflammatory Arthritis by Human Gut‐Derived Prevotella histicola in Humanized Mice. Arthritis & Rheumatology, 2016. 68(12). P. 2878-2888.
52. Mazziotta C., Tognon M., Martini F., Torreggiani E., Rotondo J.C. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells, 2023. 12(1). P. 184.
53. Mohammed A.T., Khattab M., Ahmed A.M. et al. The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials. Clin Rheumatol, 2017. 36(12). P. 2697-2707.
54. Mourand G., Paboeuf F., Grippon P. et al. Impact of Escherichia coli probiotic strains ED1a and Nissle 1917 on the excretion and gut carriage of extended-spectrum beta-lactamase-producing E. coli in pigs. Veterinary and Animal Science, 2021. 14. P. 100-217.
55. Nami Y., Vaseghi Bakhshayesh R., Mohammadzadeh Jalaly H., Lotfi H., Eslami S., Hejazi M.A. Probiotic Properties of Enterococcus Isolated From Artisanal Dairy Products. Front Microbiol, 2019. 10. P. 300.
56. Pan H., Guo R., Ju Y. et al. A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis. Microbiome, 2019. 7(1). P. 107.
57. Pan H., Li R., Li T., Wang J., Liu L. Whether Probiotic Supplementation Benefits Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Engineering, 2017. 3(1). P. 115-121.
58. Paradis T., Bègue H., Basmaciyan L., Dalle F., Bon F. Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells. IJMS, 2021. 22(5). 25-46.
59. Passali D., Passali G.C., Vesperini E. et al. The efficacy and tolerability of Streptococcus salivarius 24SMB and Streptococcus oralis 89a administered as nasal spray in the treatment of recurrent upper respiratory tract infections in children. European Review for Medical and Pharmacological Sciences, 2019. 23(1 Suppl). P. 67-72.
60. Poster Presentation Abstracts. Int J of Rheum Dis, 2016. 9(S2). P. 21-293.
61. Pretorius E., Akeredolu O.O., Soma P., Kell D.B. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med (Maywood), 2017. 242(4). P. 355-373.
62. Reyes-Castillo Z., Valdés-Miramontes E., Llamas-Covarrubias M., Muñoz-Valle J.F. Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance. Clin Exp Med, 2021. 21(1). P. 1-13.
63. Saad N, Delattre C, Urdaci M, Schmitter JM, Bressollier P.// An overview of the last advances in probiotic and prebiotic field. LWT - Food Science and Technology, 2013. 50(1). P. 1-16.
64. Safiri S., Kolahi A.A., Hoy D., et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis, 2019. 78(11). P. 1463-1471.
65. Sanchez P., Letarouilly J.G., Nguyen Y. et al. Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 2022. 14(2). P. 354.
66. Scherer H.U., Häupl T., Burmester G.R. The etiology of rheumatoid arthritis. Journal of Autoimmunity, 2020. 110. 102-400.
67. Śliżewska K., Markowiak-Kopeć P., Śliżewska W. The Role of Probiotics in Cancer Prevention. Cancers, 2020. 3(1). P. 20.
68. Smolen J.S., Aletaha D., Barton A. et al. Rheumatoid arthritis. Nat Rev Dis Primers, 2018. 4(1).180-201.
69. Stoll M.L., Pierce M.K., Watkins J.A. et al. Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis. Genes Immun, 2019. 20(2). P. 158-166.
70. Sugahara H., Odamaki T., Fukuda S. et al. Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. Sci Rep, 2015. 5(1). 135-148.
71. Tan T.G., Sefik E., Geva-Zatorsky N., et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci USA, 2016. 113(50).
72. Teng F., Klinger C.N., Felix K.M. et al. Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer’s Patch T Follicular Helper Cells. Immunity, 2016. 44(4). P. 875-888.
73. Vaghef-Mehrabany E., Alipour B., Homayouni-Rad A., Sharif S.K., Asghari-Jafarabadi M., Zavvari S. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition, 2014. 30(4). P. 430-435.
74. Vaghef-Mehrabany E., Homayouni-Rad A., Alipour B., Sharif S.K., Vaghef-Mehrabany L., Alipour-Ajiry S. Effects of Probiotic Supplementation on Oxidative Stress Indices in Women with Rheumatoid Arthritis: A Randomized Double-Blind Clinical Trial. Journal of the American College of Nutrition, 2016. 35(4). P. 291-299.
75. Wang P., Tao J.H., Pan H.F. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacol, 2016. 24(5). P. 189-196.
76. Wu X., Song M., Qiu P. et al. A metabolite of nobiletin, 4′-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis. Food Funct, 2018. 9(1). P. 87-95.
77. Wu X., Song M., Qiu P. et al. A metabolite of nobiletin, 4′-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis. Food Funct, 2018. 9(1). P. 87-95.
78. Xu H., Zhao H., Fan D. et al. Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis. Mediators of Inflammatio, 2020.9.143-165.
79. Xu X., Ocansey D.K.W., Hang S. et al. The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease. Gut Pathog, 2022. 14(1). P. 26.
80. Yadav M.K., Kumari I., Singh B., Sharma K.K., Tiwari S.K. Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Appl Microbiol Biotechnol, 2022. 106(2). P. 505-521.
81. Yan H., Ajuwon K.M. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. Koval M, ed. PLoS ONE, 2017. 12(6).
82. Yarwood A., Huizinga T.W.J., Worthington J. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA: Table 1. Rheumatology, 2016. 55(2). P. 199-209.
83. Yeşilyurt N., Yılmaz B., Ağagündüz D., Capasso R. Involvement of Probiotics and Postbiotics in the Immune System Modulation. Biologics, 2021. 1(2). P. 89-110.
84. Zamani B., Golkar H.R., Farshbaf S. et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled trial. Int J of Rheum Dis, 2016. 19(9). P. 869-879.
Количество просмотров: 1439
Категория статей:
Обзор литературы
Библиографическая ссылка
Ibraeva A.K., Latypova N.A., Kushugulova A.R., Meiramova A.M., Adilbekova B.B., Isilbaeva A.A., Kozhakhmetov S.S. Probiotics as additional treatment of Rheumatoid arthritis. A review // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (5), pp. 188-197. doi 10.34689/SH.2024.26.5.022Похожие публикации:
PROBIOTICS AS ADDITIONAL TREATMENT OF RHEUMATOID ARTHRITIS. A REVIEW.
TUBERCULOSIS: PREVALENCE, RISK FACTORS, AND FIRST-LINE DRUG RESISTANCE
АКТУАЛЬНОЕ СОСТОЯНИЕ ПРОБЛЕМЫ НАРУШЕНИЯ РАЗВИТИЯ НЕРВНОЙ СИСТЕМЫ В РАННЕМ ВОЗРАСТЕ И ПОСЛЕДУЮЩЕЕ ВМЕШАТЕЛЬСТВО. ОБЗОР ЛИТЕРАТУРЫ.
PROGNOSTIC SIGNIFICANCE OF GENETIC TUMOR MARKERS IN THYROID NEOPLASMS: LITERATURE REVIEW
CHARACTERIZING THE ROLE OF ABCG5/G8 IN SITOSTEROLEMIA: DIAGNOSTIC CHALLENGES IN DIFFERENTIATING FROM FAMILIAL HYPERCHOLESTEROLEMIA